ADMA Biologics ADMA Payments of Financing Costs
Payments of Financing Costs at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfFinancingCosts.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is ADMA Biologics's payments of financing costs?
- ADMA Biologics (ADMA) reported payments of financing costs of $0 in Q4 2025.
- What is the long-term trend for ADMA Biologics's payments of financing costs?
- Over 2 years (2023 to 2025), ADMA Biologics's payments of financing costs has grown at a -100.0% compound annual growth rate (CAGR), from $2.35M to $0.
- What does payments of financing costs mean?
- Aggregates all cash outflows related to the procurement or maintenance of debt and equity financing. This provides a comprehensive view of the costs associated with maintaining the company's capital structure.